Back to Search
Start Over
Copanlisib, a PI3K Inhibitor, Demonstrates a Favorable Long-Term Safety Profile in a Pooled Analysis of Patients with Hematologic Malignancies
- Authors :
- Zinzani, Pier Luigi Santoro, Armando Mollica, Luigina Leppa, Sirpa Follows, George A. Lenz, Georg Kim, Won Seog and Nagler, Arnon Panayiotidis, Panayiotis Demeter, Judit and Morschhauser, Franck Munoz, Javier Miriyala, Ashok Benson, Alice Garcia-Vargas, Jose Childs, Barrett H. Dreyling, Martin
- Publication Year :
- 2019
Details
- Language :
- English
- Database :
- OpenAIRE
- Accession number :
- edsair.od......2127..a33f90659ad4e8c8bb155a4a0d1b3406